Abuse-Deterrence

    Abuse-Deterrent.jpg

    Abuse of prescription medications is a critical issue in the United States and its neighboring countries. In an effort to control this epidemic, the FDA has recently updated their guidelines on opioid formulations to now employ strategies to reduce or eliminate the potential for abuse and misuse.  

    The FDA now requires that a scientifically rigorous laboratory-based in-vitro manipulation and extraction study be performed to evaluate how easily said product may be abused or comprised. 

    Download White Paper Here

    Key Concepts of Abuse-Deterrence Studies

    • Various types of physical manipulation, reflecting actual and speculative abuse techniques
    • Extractability and solubility studies designed around an understanding of the chemical characteristics of the active and excipient components
    • Determination of a valid comparator
    • Complex analytical methodology due to the wide variety of matrices encountered
    • Particle size characterization for drugs that may be crushed and inhaled, and evaluation of the ease/difficulty of pushing through a syringe for drugs that may be injected

    Why Perform These Studies?

    • Required by the FDA and Health Canada for new opioid formulations, and may soon be required in Europe
    • Necessary for NDA filings
    • Products with these studies are placed on the FDA fast track and often given priority approval
    • May reduce the scope (and cost) of subsequent pharmacokinetic and clinical studies
    • Prominent politicians in the United States have highlighted this issue as the nation’s fastest-growing drug problem and requested regulation supporting abuse-deterrence programs
    • Gain the marketing advantage over competitors for other products with the propensity for abuse
    Learn More About Alcami's Abuse-Deterrence Services

    Benefit of Alcami's Services

    • Experienced experts performing abuse-deterrence studies per FDA guidelines
    • Full GMP traceability
    • Experience building challenges into the study
    • Success in a number of studies used for NDA filings
    • Capability to perform preliminary studies to determine study conditions and minimize the chance of issues occurring throughout the study
    • Excellent reputation for responsiveness, problem-solving and reliable outcomes
    • cGMP compliant with robust quality systems
    • Exemplary compliance record
    • Experienced project management team ensures scope and timeline are communicated and achieved
    • Flexibility to change the project scope, as needed
    • Full range of complementary development and manufacturing services to support other needs
    • Access to knowledge gained from five years of experience interpreting the general guidance across multiple programs – no two programs are the same

    Connect with an Expert

    Abuse Deterrent Info_graphic-2.png